MAM
Singapore’s Media Development Authority appoints Priority PR for global campaign
MUMBAI: Priority Public Relations has been named the AoR for Singapore’s Media Development Authority, a government agency created in part to develop global awareness of Singapore’s media industry. The announcement was made by Priority Public Relations vice president and managing director Europe Marylou Johnston.
According to an official statement, Priority Public Relations is charged with perpetuating the MDA’s Singapore Media Fusion initiative which celebrates the achievements and supports the continued development of Singapore’s media industry.
Serving as both a common voice for Singapore’s production community while also spearheading international exposure and support for the region’s co-production projects, including HD and animation, and the growing demand for Singapore’s products and services, Priority Public Relations will handle global trade and business media coverage of the Singapore Media Fusion initiative and its resulting projects and alliances.
Priority Public Relations assisted the MDA in launching the Singapore Media Fusion initiative in October of 2006. In conjunction with the Singapore Media Fusion initiative, MDA also launched a portal (http://www.singaporemediafusion.com) in October 2006, cultivating an online media community that offers information on Singapore’s media industry and opportunities, samples of made-by-Singapore content and fosters idea sharing between local Singapore media professionals and executives in the worldwide media marketplace.
Media Development Authority (MDA) was formed by the merger of the Singapore Broadcasting Authority, the Films and Publications Department, and the Singapore Film Commission (SFC), on 1 January 2003, to focus on and develop Singapore as a state of the art media city.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
